Thyroid fibromatosis is a very rare lesion; to our knowledge, there are only four cases reported in the medical literature. Herein, we report the clinical case of a woman with thyroid fibromatosis with a long follow-up (11 years). A 63-yearold female patient, with an increasing multinodular goitre without compressive symptoms, was admitted to total thyroidectomy. The histology revealed a spindle-cell proliferation with fibroblastic characteristics with no atypia and thin capillary vessels. Immunohistochemistry was positive for beta-catenin, focally to desmin and alfa-actin and negative for cytokeratins and CD34. Thyroid cells did not display any features of papillary thyroid cancer. These characteristics were compatible with thyroid fibromatosis. For the past 11 years, the patient has been periodically followed up with neck CTs and she has not shown any signs of recurrence. Thyroid fibromatosis has been associated with invasion of surrounding structures in previous reported cases. However, this aggressive behaviour was not observed in our patient. The most challenging differential diagnosis is with papillary thyroid cancer with fibromatosis-like stroma, in which the malignant component is usually peripheral. Therefore, in these cases, it is mandatory to perform an extensive examination of the resected sample.
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Learning points:
• Fibromatosis is a mesenchymal lesion that consists of an infiltrative proliferation of fibroblasts without atypia.
• Thyroid fibromatosis is a rare entity in this gland. In previously reported cases, it has been associated with an invasive behaviour but this was not the case in our patient.
• When spindle-cell proliferation with fibroblastic/myofibroblastic characteristics is detected on thyroid histology, it is mandatory to exclude a papillary thyroid carcinoma with fibromatosis-like stroma.
Background
Thyroid fibromatosis is a very rare lesion. To the best of our knowledge, only four cases have been reported in the literature (1, 2, 3) , which makes this diagnosis a poorly defined entity in terms of clinical outcome. Fibromatosis represents a tumour-like lesion originating from the fascia and musculoaponeurotic tissue, frequently with local aggressive behaviour. Only 10% of these lesions occur in cervical region (4, 5) , and thyroid involvement is even less frequent. Cervical fibromatosis can present an infiltrative growth pattern putting at risk important structures of the neck, but it does not metastasize (6) . Fibromatosis may also evolve with local recurrence (7) . Herein, we report the clinical case of a woman with thyroid fibromatosis with 11-years of follow-up. 
Investigation
A multinodular goitre was detected and she was submitted to FNAC of one of the nodules, which revealed a colloid goitre. Detailed descriptions of thyroid ultrasound and thyroid function tests taken at that time were not available.
Treatment
She was then submitted to total thyroidectomy.
Outcome and follow-up
The resected piece revealed a nodule measuring 55 × 40 × 30 mm with fibrous consistency and fascicular aspect; the remaining parenchyma evidenced a nodular surface with colloid brightness. On microscopic examination a spindle-cell proliferation with fibroblastic/myofibroblastic characteristics with no atypia, thin capillary vessels and perivascular oedema were observed (Fig. 1) . Immunohistochemistry was positive for beta-catenin, focally for desmin and negative for cytokeratins, CD34 and alfa-actin (Fig. 2) . So, the resected nodule corresponded to the fibromatosis component surrounded by colloid goitre. Papillary thyroid cancer was not found after extensive sampling. These features were compatible with thyroid fibromatosis.
After thyroidectomy, she developed dysphonia and dyspnoea due to paralysis of both vocal chords. CO 2 laser posterior cordotomy of the left vocal chord was performed post-operatively, dyspnoea worsened and the patient was submitted to urgent tracheostomy. In the following 5 years, several surgeries were attempted to decannulate her but were unsuccessful. The first two surgical approaches consisted of CO 2 laser posterior cordotomy of the left vocal chord and the third surgery of CO 2 laser posterior cordotomy on the right side. Her last surgery, 4 years after the thyroidectomy, consisted of a laryngoplasty. Unfortunately, her glottic lumen was not sufficient to allow decannulation. In all of these surgeries, peri-tracheostomal granulation tissue was surgically removed. Histological examination of biopsies taken at those surgeries did not reveal any loco-regional invasion or recurrence of the original lesion. For the past 11 years, the patient has been Immunohistochemistry showed negativity for cytokeratins AE1/AE3 (A) and CAM5.2 (B), CD34 (C) and smooth-muscle actin (D). There was very weak and focal staining for desmin (E) and nuclear positivity for β-catenin (F).
periodically followed up with neck CTs and she has not shown any signs of recurrence. TSH has been within the normal range, under supplementation with levothyroxine, and serum thyroglobulin levels have remained stable between 0.3 and 2.0 ng/mL (with negative anti-thyroglobulin antibodies).
Discussion
Fibromatosis is a mesenchymal lesion that consists of an infiltrative proliferation of fibroblasts without atypia. Neck fibromatosis is usually associated with invasion of surrounding structures. In fact, three of the four previously described cases of thyroid fibromatosis, evidenced invasion of the surrounding structures (muscles, vessels, etc.) (1, 2, 3), but complications deriving from the thyroidectomy were not clearly described in those cases. This infiltrative behaviour was not observed in our patient -we admit that this non-invasive behaviour was related to the fact that the fibromatosis component corresponded to a welldefined nodule, measuring 55 mm, restricted to the thyroid. We believe that her vocal chords paralysis was caused by injury of laryngeal nerves during surgery, given that she only complained of dysphonia and dyspnoea after thyroidectomy. Another interesting fact of this clinical entity is its pathogenesis -one of the patients reported by Schwarlmüller et al. (3) evidenced a previous history of neck injury with a wire and, therefore, the fibromatosis was considered to be a fibrous proliferative reaction to a foreign body.
A short description of the four reported cases is displayed in Table 1 .
The differential diagnosis of a progressively enlarging and firm thyroid gland usually includes uncommon conditions like anaplastic or poorly differentiated thyroid carcinoma, primary thyroid lymphoma or Riedel thyroiditis. Thyroid fibromatosis is an even more rare cause of thyroid growth. When spindlecell proliferation with fibroblastic/myofibroblastic characteristics is detected on thyroid histology, it is mandatory to exclude a papillary thyroid carcinoma with fibromatosis-like stroma (PTC-FLS), which represents only a tiny fraction (up to 0.5%) of all PTCs (8) . The stromal reaction usually represents 60-80% of the tumour volume, exhibiting characteristics of both fibroblasts and smooth-muscle cells, suggesting that it is derived from myofibroblasts. The pathogenesis of the stromal component is still a matter of debate: some authors believe that it can represent a reactive proliferation to some form of injury (as in the case reported by Schwarzlmüller et al. (3) ), while others advocate an autonomous proliferation of stromal cells (9) . It may be difficult to obtain a correct diagnosis of PTC-FLS by FNAC, given that most of it is composed by a bulky stroma, making the aspiration of the malignant component hard to obtain. Moreover, as previously shown (10), the malignant epithelial component, containing cells with clear and grooved nuclei, is usually located at the periphery of the tumour, which may be missed by the pathologist. Therefore, when thyroid fibromatosis is diagnosed, PTC-FLS should be carefully excluded. Given the rarity of thyroid fibromatosis, there are no formal recommendations in the literature to follow these patients. In one of the four published cases of thyroid fibromatosis, the patient evidenced a local recurrence 4 years after thyroidectomy (3) so we decided to follow this patient annually, not only to exclude any local recurrence, but also to determine serum thyroglobulin levels considering the difficult differential diagnosis with PTC-FLS. Our clinical report describes the case of a patient with thyroid fibromatosis with the longest (11 years) follow-up reported to date and, so far, no signs of recurrence have become apparent.
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